ARCHIVE

• REGULATORY NEWS IN BRIEF
  November 11, 2002

• CDFS's Panel on Medical Devices to Prepare for New PAL Enforcement
  November 11, 2002

• REGULATORY BULLETIN
  November 4, 2002

• DIAGNOSTIC NEWS IN BRIEF
  November 4, 2002

• Kissei Licenses Novel Antidiabetic Agent to GSK
  November 4, 2002

• NEW PRODUCTS
  November 4, 2002

• Kowa Developing Anti-inflammatory Drugs with Pharmacopoeia of the US
  November 4, 2002

• CORPORATE ROUNDUP NEWS IN BRIEF
  November 4, 2002

• Expecting Synergism in Collaboration with Ranbaxy: Mr Yamaguchi of Nippon Chemiphar
  November 4, 2002

• Law on New Drug Organization to Be Presented to Diet
  November 4, 2002

• Benesis to Concentrate on Stable Supply of Safe Blood Products
  November 4, 2002

• Insurer Regrouping to Make Medical Fees Vary from One Prefecture to Another: Korosho Official
  November 4, 2002

• FJPWA Withholds Conclusion on Cooperation in Preliminary Drug Price Survey
  November 4, 2002

• EU Presents Proposals for Regulatory Reform in Japan
  November 4, 2002

• Price Settlement Rate 53.5% at the End of September: VITAL-NET
  November 4, 2002

• REGULATORY NEWS IN BRIEF
  November 4, 2002

• Bio Drugs to Account for 30% of All Drugs in 2010: Mr Nagayama at Medical Forum
  November 4, 2002

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  November 4, 2002

• Kuraya Sanseido to Achieve 2% Operating Profit Rate by Further Cutting Costs
  November 4, 2002

• Takeda Develops Simulation Software to Predict Prognosis of Diabetic Complications
  November 4, 2002

ページ

• « 先頭
• ‹ Prev
• …
• 641
• 642
• 643
• 644
• 645
• 646
• 647
• 648
• 649
• …
• Next ›
• 最終 »